Coherus BioSciences, Inc. (NASDAQ:CHRS) Q2 2023 Earnings Cal

Operator: Good day and thank you for standing by. Welcome to the Coherus Biosciences Second Quarter 2023 Conference Call. At this time all participants are in a listen-only mode.

Related Keywords

United States , Junshi , Anhui , China , American , Chris Schott , Theresa Lavallee , Douglas Tsao , Mcdavid Stilwell , Balaji Prasad , Mark Cuban , Marek Ciszewski , Rosh Dias , Robyn Karnauskas , Michael Nedelcovych , Jason Gerberry , Coherus Biosciences , Paul Reider , Denny Lanfear , Neulasta Onpro , Coherus Biosciences Inc , Amgen , Mark Cuban Cost Plus Drugs Company , Nasdaq , Charming Shoppes Inc , Team Cuban Card , American Society Of Retina Specialists , Call Transcript August , Coherus Biosciences Second Quarter , Surface Oncology , Chief Development Officer , Chief Medical Officer , Chief Commercial Officer , Chief Financial , Chief Financial Officer , Superior Biologics , David Stilwell , Unidentified Analyst , Thanks Denny , Tori Orphan Drug Designation , American Society , Retina Specialists , Yash Verma , Analyst Day ,